CorMedix (CRMD) Tax Rate (2011 - 2026)

CorMedix (CRMD) posted Tax Rate of 120.86% for Q4 2025, up 213.5% sequentially from 106.49% in Q3 2025, and up 12087.0% YoY from N/an in Q4 2024.

CorMedix (CRMD) Tax Rate (2011 - 2026) Analysis & Trends

CorMedix has reported Tax Rate for 9 years, with the latest figure at 120.86% in Q4 2025.

Quarterly Tax Rate rose 12087.0% year-over-year to 120.86% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 8.5% (up 129.0% YoY) and the FY2025 annual result came in at 8.5%, up 129.0% from the prior year.
Tax Rate rose to 120.86% in Q4 2025 per CRMD's latest filing, from 106.49% in the prior quarter.
Over five years, Tax Rate peaked at 120.86% in Q4 2025 and troughed at 106.49% in Q3 2025.
A 4-year average of 2.99% and a median of 1.3% in 2024 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 12087 bps in 2025, down 10630 bps in 2025.
Over 4 years, Tax Rate stood at 24.08% in 2021, then soared by 130 bps to 7.15% in 2022, then sank by 100 bps to 0.0% in 2024, then soared by 7075462 bps to 120.86% in 2025.
According to Business Quant data, Tax Rate over the past three periods registered 120.86%, 106.49%, and 2.56% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	15.11%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	10.91%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	34.12%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	CorMedix	645.20 Mn	388.51 Mn	77.13 Mn	32.90%

Download Data